Basiliximab - Novartis
At a glance
- Drug Originator Novartis
- Drug Licenced by Cerimon Pharmaceuticals
- Drug Class Monoclonal antibodies
- Mechanism of Action Immunosuppressants; Interleukin 2 receptor antagonists
- USA Patent Applicants NOVARTIS
- USA Patents 169
- BLAs 1
- International Patents 2,157

Disclaimer